Technical Analysis for ANVS - Annovis Bio, Inc.

Grade Last Price % Change Price Change
F 9.39 3.30% 0.30
ANVS closed up 3.3 percent on Monday, March 18, 2024, on 65 percent of normal volume.
Earnings due: Apr 1
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish 3.30%
Bollinger Band Squeeze Range Contraction 3.30%
BB Squeeze Started Range Contraction 3.30%
NR7 Range Contraction 5.27%
Narrow Range Bar Range Contraction 5.27%

   Recent Intraday Alerts

Alert Time
Up 10% about 12 hours ago
1.5x Volume Pace about 14 hours ago
Rose Above 20 DMA about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Up 5% about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Nervous System Amyloid Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes

Is ANVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.7
52 Week Low 5.42
Average Volume 245,209
200-Day Moving Average 11.05
50-Day Moving Average 10.42
20-Day Moving Average 9.28
10-Day Moving Average 9.10
Average True Range 0.76
RSI (14) 47.92
ADX 11.99
+DI 22.45
-DI 17.47
Chandelier Exit (Long, 3 ATRs) 9.35
Chandelier Exit (Short, 3 ATRs) 10.39
Upper Bollinger Bands 10.29
Lower Bollinger Band 8.26
Percent B (%b) 0.56
BandWidth 21.85
MACD Line -0.38
MACD Signal Line -0.48
MACD Histogram 0.0949
Fundamentals Value
Market Cap 99.35 Million
Num Shares 10.6 Million
EPS -4.84
Price-to-Earnings (P/E) Ratio -1.94
Price-to-Sales 0.00
Price-to-Book 17.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.49
Resistance 3 (R3) 10.58 10.32 10.30
Resistance 2 (R2) 10.32 10.04 10.27 10.24
Resistance 1 (R1) 9.85 9.87 9.72 9.76 10.18
Pivot Point 9.59 9.59 9.52 9.54 9.59
Support 1 (S1) 9.12 9.31 8.99 9.03 8.60
Support 2 (S2) 8.86 9.14 8.81 8.54
Support 3 (S3) 8.39 8.86 8.48
Support 4 (S4) 8.30